Celgene Corporation (CELG) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

75% of 4 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks

Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
Netteligent Netteligent 06/04/2016 1 month $107.59 $100.67 -6.43% 6 Active
Comments: Zombie Walking. Slow Growth. High Risk
iidakuj iidakuj 05/16/2016 1 Year $101.57 $100.67 -0.89% -1 Active
Comments:
hghg hghg 04/30/2016 3 months $103.42 $100.67 -2.66% -2 Active
Comments: all Short selling
RichardSanchez RichardSanchez 01/14/2016 3 months $105.62 $105.26 -0.34% -1 Ended
Comments:
Chrisyahahha Chrisyahahha 01/14/2016 3 months $102.84 $105.26 +2.35% -2 Ended
Comments:
Butler1 Butler1 10/11/2015 1 Year $117.38 $100.67 -14.24% -14 Active
Comments:
B1capital B1capital 07/06/2015 3 months $119.52 $116.44 -2.58% -2 Ended
Comments:
JLSR JLSR 06/27/2015 3 months $117.92 $113.88 -3.43% -3 Ended
Comments:
fabdalpiero fabdalpiero 05/06/2015 3 months $108.65 $131.47 +21% 21 Ended
Comments: buy on average with rising target by the end of the period.
robertsacct robertsacct 10/29/2014 1 Year $105.23 $127.14 +20.82% 20 Ended
Comments:
wrcornett717 wrcornett717 10/21/2014 1 Year $94.97 $116.24 +22.4% 22 Ended
Comments: Projecting strong long-term growth
Optioned Optioned 04/10/2014 3 months $147.32 $85.72 -41.81% -41 Ended
Comments: Initiated my position 04/09/14. Will use $5 trailing stop. Bought May 14 130 calls.
Yongmang Yongmang 12/27/2013 1 Year $168.93 $113.35 -32.9% -32 Ended
Comments:
JOKER66 JOKER66 11/12/2012 3 months $71.50 $75.60 +5.73% 5 Ended
Comments:
suryajaya06 suryajaya06 11/07/2011 1 Year $63.73 $67.98 +6.67% 6 Ended
Comments: Industry sector growing or poised for growth
quirino quirino 03/08/2010 3 months N/A Ended
Comments: 70?

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.